Cargando…
The roles of T cell competition and stochastic extinction events in chimeric antigen receptor T cell therapy
Chimeric antigen receptor (CAR) T cell therapy is a remarkably effective immunotherapy that relies on in vivo expansion of engineered CAR T cells, after lymphodepletion (LD) by chemotherapy. The quantitative laws underlying this expansion and subsequent tumour eradication remain unknown. We develop...
Autores principales: | Kimmel, Gregory J., Locke, Frederick L., Altrock, Philipp M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059581/ https://www.ncbi.nlm.nih.gov/pubmed/33757357 http://dx.doi.org/10.1098/rspb.2021.0229 |
Ejemplares similares
-
Correction to ‘The roles of T-cell competition and stochastic extinction events in CAR T-cell therapy’
por: Kimmel, Gregory J., et al.
Publicado: (2022) -
Extinction risk and conservation of the world’s sharks and rays
por: Dulvy, Nicholas K, et al.
Publicado: (2014) -
Case of Myocarditis After Chimeric Antigen Receptor T Cells With Intracardiac Lymphoma
por: Lee, Dae Hyun, et al.
Publicado: (2022) -
Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies
por: Schorr, Christopher, et al.
Publicado: (2023) -
Chimeric antigen receptor T-cell therapy
por: Burge, Cale, et al.
Publicado: (2023)